{"id":12962,"date":"2021-09-10T12:34:36","date_gmt":"2021-09-10T12:34:36","guid":{"rendered":"https:\/\/haberglobal.com.tr\/gundem\/prof-dr-alpay-azap-tan-koronavirusle-ilgili-dikkat-ceken-aciklama-6-9-ay-icinde-131779"},"modified":"2021-09-10T12:34:36","modified_gmt":"2021-09-10T12:34:36","slug":"prof-dr-alpay-azaptan-koronavirusle-ilgili-dikkat-ceken-aciklama-6-9-ay-icinde","status":"publish","type":"post","link":"https:\/\/istanbulchannel.net\/index.php\/2021\/09\/10\/prof-dr-alpay-azaptan-koronavirusle-ilgili-dikkat-ceken-aciklama-6-9-ay-icinde\/","title":{"rendered":"Prof. Dr. Alpay Azap’tan koronavir\u00fcsle ilgili dikkat \u00e7eken a\u00e7\u0131klama: 6-9 ay i\u00e7inde…"},"content":{"rendered":"

<\/p>\n

<\/div>\n

T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Derne\u011fi (KL\u0130M\u0130K) taraf\u0131ndan \u0130stanbul’da d\u00fczenlenen ve t\u00fcm T\u00fcrkiye’den enfeksiyon hastal\u0131klar\u0131 ve klinik mikrobiyoloji uzman\u0131 400’e yak\u0131n hekimin kat\u0131ld\u0131\u011f\u0131 “KL\u0130M\u0130K COVID-19 Simpozyumu”nda SARS-COV-2 vir\u00fcs\u00fc son bilimsel geli\u015fmelerle b\u00fct\u00fcn y\u00f6nleriyle masaya yat\u0131r\u0131ld\u0131. D\u00fczenlenen bas\u0131n toplant\u0131s\u0131na KL\u0130M\u0130K Ba\u015fkan\u0131 Prof. Dr. Alpay Azap, Genel Sekreteri ve Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Bilim Kurulu \u00dcyesi Prof. Dr. Serap \u015eim\u015fek Yavuz, Dernek Y\u00f6netim Kurulu \u00dcyeleri Prof. Dr. B\u00fclent Ertu\u011frul, Do\u00e7. Dr. S\u00fcda Tekin ve Prof. Dr. Ne\u015fe Demirt\u00fcrk ile Do\u00e7. Dr. Mehtap Ayd\u0131n kat\u0131ld\u0131. Bas\u0131n toplant\u0131s\u0131nda konu\u015fan Prof. Dr. Alpay Azap, ‘2 y\u0131l \u00f6ncesine bakt\u0131\u011f\u0131m\u0131zda Covid-19’da geldi\u011fimiz noktan\u0131n olduk\u00e7a iyi oldu\u011funu s\u00f6yleyerek “Olduk\u00e7a etkili a\u015f\u0131lara sahibiz. Elbette hastal\u0131\u011f\u0131n t\u00fcm d\u00fcnyada kontrol alt\u0131na al\u0131nabilmesi i\u00e7in \u00fclkelerde e\u015fit ve yayg\u0131n a\u015f\u0131lama son derece \u00f6nemli. Bu sa\u011flanana kadar da a\u015f\u0131yla birlikte di\u011fer \u00f6nlemlerin de devam etmesi gerekiyor” dedi.<\/p>\n

“MU VARYANTI HEN\u00dcZ ‘END\u0130\u015eE VARYANTI’ KATEGOR\u0130S\u0130NDE DE\u011e\u0130L”<\/strong><\/p>\n

SARS-CoV-2’nin beklenenden daha fazla mutasyon ge\u00e7irmesinin en \u00f6nemli nedenlerinden birinin, enfeksiyonun kontrols\u00fcz bir \u015fekilde h\u0131zla yay\u0131lmas\u0131 oldu\u011funa dikkat \u00e7eken Prof. Dr. Azap, \u015fu ana kadar 4 adet ‘endi\u015fe yaratan varyant’ tan\u0131mlanm\u0131\u015f oldu\u011funu ancak Mu varyant\u0131n\u0131n hen\u00fcz bunlardan biri olmad\u0131\u011f\u0131n\u0131 s\u00f6yledi. Prof. Dr. Azap, “Ancak dikkatle takip edilmesi gereken bir varyant. Delta’n\u0131n bula\u015fma h\u0131z\u0131 ile k\u0131yasland\u0131\u011f\u0131nda Mu varyant\u0131 yar\u0131\u015f\u0131 kaybediyor. Delta \u00e7ok daha bula\u015f\u0131c\u0131 oldu\u011fu i\u00e7in Mu varyant\u0131n\u0131n toplumdaki yay\u0131l\u0131m\u0131n\u0131 bask\u0131l\u0131yor. Ama Mu varyant\u0131n\u0131n da (kendi a\u00e7\u0131c\u0131ndan) \u015f\u00f6yle bir avantaj\u0131 var, \u00f6n veriler de bunu s\u00f6yl\u00fcyor, Delta’ya nazaran a\u015f\u0131lara biraz daha dayan\u0131kl\u0131. A\u015f\u0131lanm\u0131\u015f veya hastal\u0131\u011f\u0131 ge\u00e7irmi\u015f ki\u015filerde, Delta’ya k\u0131yasla daha avantajl\u0131 bu bak\u0131mdan. Delta gibi birka\u00e7 ay i\u00e7erisinde b\u00fct\u00fcn topluma yay\u0131lm\u0131yor hen\u00fcz. D\u00fc\u015f\u00fck bir oranda, y\u00fczde 10’un alt\u0131nda seyrediyor g\u00f6r\u00fcld\u00fc\u011f\u00fc \u00fclkelerde. Ama \u015f\u00f6yle bir tehdit var, o y\u00fczden \u00e7ok yak\u0131n izliyoruz, insanlarda dola\u015fmaya devam etti\u011fi i\u00e7in hastal\u0131k yapt\u0131k\u00e7a de\u011fi\u015fime u\u011frama riski var. \u00dczerinde mutasyon biriktirme riski var ve bu kazand\u0131\u011f\u0131 yeni mutasyonlar onu Delta’dan daha avantajl\u0131 hale getirebilir yay\u0131l\u0131m a\u00e7\u0131s\u0131ndan. Birdenbire nas\u0131l Delta Alfa varyant\u0131n\u0131 s\u00fcp\u00fcrd\u00fcyse Mu varyant\u0131 da Delta’y\u0131 s\u00fcp\u00fcrebilir ve bu da a\u015f\u0131lar\u0131n etkisini azaltabilir. \u0130\u015fte bizim b\u00fct\u00fcn gayretimiz, b\u00fct\u00fcn d\u00fcnyan\u0131n gayreti, a\u015f\u0131dan ka\u00e7an daha bula\u015f\u0131c\u0131 varyantlar \u00e7\u0131kmadan \u00f6nce salg\u0131n\u0131 kontrol alt\u0131na alabilmek” diye konu\u015ftu.<\/p>\n

“K\u00d6T\u00dc A\u015eI YOK, SADECE UZUN S\u00dcRE KORUMA DOZLARINI HEN\u00dcZ B\u0130LM\u0130YORUZ”<\/strong><\/p>\n

Prof. Dr. Alpay Azap, \u015fu an kullan\u0131mda olan a\u015f\u0131lar\u0131n hi\u00e7birisi i\u00e7in “k\u00f6t\u00fc a\u015f\u0131” olarak nitelendirilemeyece\u011fini s\u00f6yleyerek s\u00f6zlerini \u015f\u00f6yle s\u00fcrd\u00fcrd\u00fc: “\u015eu anda acil kullan\u0131m onay\u0131 alm\u0131\u015f 12 farkl\u0131 a\u015f\u0131n\u0131n hepsi, DS\u00d6’n\u00fcn istemi\u015f oldu\u011fu y\u00fczde 50’den daha fazla korumay\u0131 sa\u011fl\u0131yor. Ama b\u00fct\u00fcn a\u015f\u0131lar i\u00e7in \u015f\u00f6yle bir sorun var, hen\u00fcz bir insan\u0131 uzun s\u00fcreli hastal\u0131ktan koruyacak primer doz \u015femas\u0131 belli olmad\u0131. \u00d6rne\u011fin bu, Hepatit B i\u00e7in 0, 1 ve 6. aylarda yap\u0131lan 3 doz a\u015f\u0131d\u0131r. Hepatit A i\u00e7in 0 ve 6. aylarda yap\u0131lan 2 doz a\u015f\u0131d\u0131r. Bizim \u00fclkemizde uygulanan her iki a\u015f\u0131 i\u00e7in de bir 3. doz gereklili\u011fi var gibi g\u00f6r\u00fcn\u00fcyor. Ama bu 3. dozun aral\u0131\u011f\u0131 inaktif vir\u00fcs a\u015f\u0131s\u0131nda (Sinovac) ba\u011f\u0131\u015f\u0131kl\u0131k daha erken azald\u0131\u011f\u0131 i\u00e7in 3 ay gibi makul g\u00f6r\u00fcn\u00fcrken BioNTech i\u00e7in 8-9 ay olacak gibi g\u00f6r\u00fcn\u00fcyor.”<\/p>\n

“SEYAHAT \u0130\u00c7\u0130N 4. DOZ OLMAZ, D\u00dcNYADA BUNUN D\u00dcZELT\u0130LMES\u0130 LAZIM”<\/strong><\/p>\n

Belli risk grubu d\u0131\u015f\u0131ndakiler i\u00e7in BioNTech a\u015f\u0131s\u0131nda iki dozun \u00fczerine 3. dozun hen\u00fcz gerekli olmad\u0131\u011f\u0131n\u0131 da vurgulayan Prof. Dr. Azap, “\u00c7\u00fcnk\u00fc mRNA a\u015f\u0131lar\u0131nda 2 dozun da a\u011f\u0131r hastal\u0131k ve \u00f6l\u00fcmden korumaya etkisi epeyce uzun devam ediyor. Ama baz\u0131 risk gruplar\u0131na yap\u0131lmas\u0131 faydal\u0131 olabilir. Zaten d\u00fcnyadaki pek \u00e7ok \u00fclke bunu yap\u0131yor, DS\u00d6 de tam olarak bunu s\u00f6yl\u00fcyor. Zira d\u00fcnya’n\u0131n tamam\u0131nda a\u015f\u0131lamay\u0131 belli bir orana ula\u015ft\u0131ramadan \u00fc\u00e7\u00fcnc\u00fc dozlara ge\u00e7seniz bile, a\u015f\u0131lanman\u0131n d\u00fc\u015f\u00fck yap\u0131ld\u0131\u011f\u0131 \u00fclkelerde vir\u00fcs de\u011fi\u015fime u\u011fray\u0131p a\u015f\u0131dan ka\u00e7abilir hale gelecek. Ondan sonra da siz toplumun y\u00fczde 90’\u0131n\u0131 3 doz a\u015f\u0131lsan\u0131z bile insanlar hasta olacak. B\u00fct\u00fcn a\u015f\u0131lama \u00e7\u00f6pe gitmi\u015f olacak. Biz KL\u0130M\u0130K Derne\u011fi olarak da zaten \u00f6zellikle Sinovac sonras\u0131 3. Dozunu BioNTech ile olanlar\u0131n 4 dozdan ka\u00e7\u0131nmas\u0131 gerekti\u011fine dikkat \u00e7ektik. Maalesef d\u00fcnya bu konuda \u00e7ok k\u00f6t\u00fc bir s\u0131nav veriyor. Seyahat gereklili\u011fi y\u00fcz\u00fcnden insanlar gerekmedi\u011fi halde 4. dozlar\u0131n\u0131 olmak zorunda kal\u0131yorlar. DS\u00d6 gibi kurumlar\u0131n bunu d\u00fczeltmesi laz\u0131m” \u015feklinde konu\u015ftu.<\/p>\n

“A\u015eILANAN \u0130K\u0130 KAT DAHA AZ BULA\u015eTIRIYOR”<\/strong><\/p>\n

A\u015f\u0131 kar\u015f\u0131tlar\u0131n\u0131n “A\u015f\u0131lananlar da bula\u015ft\u0131r\u0131yor, hastalan\u0131yor, a\u015f\u0131 i\u015fe yaram\u0131yor” iddialar\u0131na da yan\u0131t veren Prof. Dr. Azap, s\u00f6zlerini \u015f\u00f6yle s\u00fcrd\u00fcrd\u00fc: “Bu \u00e7ok yanl\u0131\u015f. A\u015f\u0131lananlar hastalansa da her zaman a\u015f\u0131lanmayanlara g\u00f6re daha az bula\u015ft\u0131r\u0131yor. \u0130ngiltere’de \u00e7ok g\u00fczel bir \u00e7al\u0131\u015fma \u015funu g\u00f6sterdi bize, a\u015f\u0131lanm\u0131\u015f bir birey hastalansa ayn\u0131 hanede ev halk\u0131na hastal\u0131\u011f\u0131 bula\u015ft\u0131rma riski a\u015f\u0131s\u0131zlara g\u00f6re yar\u0131 yar\u0131ya d\u00fc\u015f\u00fck. Yani bir evde 4 ki\u015fi ya\u015f\u0131yorsa, a\u015f\u0131lanmam\u0131\u015f biri hastal\u0131\u011f\u0131 2 ki\u015fiye bula\u015ft\u0131r\u0131rken a\u015f\u0131l\u0131 birey sadece 1 ki\u015fiyi enfekte ediyor. ‘Nas\u0131l olsa hastalanaca\u011f\u0131m’ diye bir \u015fey yok. Hastalanma olas\u0131l\u0131\u011f\u0131n\u0131z\u0131 da y\u00fczde 60’dan fazla azalt\u0131yor t\u00fcm a\u015f\u0131lar. Ayr\u0131ca hastalansan\u0131z dahi kesin olarak hafif ge\u00e7irmenizi sa\u011fl\u0131yor. Hastal\u0131\u011f\u0131 \u015fiddetli ge\u00e7irdi\u011finiz zaman hasar kalma riski \u00e7ok daha y\u00fcksek. Akci\u011ferlerde hasara, fel\u00e7 gibi, kalp krizi gibi durumlara sebep olabiliyor. Dolay\u0131s\u0131yla hafif ge\u00e7irdi\u011finiz zaman, bunlardan da korunuyorsunuz.”<\/p>\n

“YEN\u0130 \u0130LA\u00c7LAR DA PANDEM\u0130N\u0130N B\u0130T\u0130\u015e\u0130NE YARDIM EDECEK”<\/strong><\/p>\n

D\u00fcnyada a\u015f\u0131laman\u0131n h\u0131zlanmas\u0131, a\u015f\u0131lama oranlar\u0131n\u0131n artmas\u0131 ve en \u00f6nemlisi bu vir\u00fcs\u00fc etkili bir \u015fekilde durdurabilecek ve a\u011f\u0131zdan kullan\u0131lacak hap \u015feklindeki kolay uygulanabilecek ila\u00e7lar\u0131n da birka\u00e7 ay i\u00e7erisinde kullan\u0131ma girecek olmas\u0131 sayesinde Covid-19 pandemisinin ‘endemiye’ d\u00f6n\u00fc\u015fece\u011fini d\u00fc\u015f\u00fcnd\u00fc\u011f\u00fcn\u00fc vurgulayan Prof. Dr. Azap, \u015funlar\u0131 s\u00f6yleyerek s\u00f6zlerini noktalad\u0131: “6-9 ay i\u00e7erisinde bu hastal\u0131\u011f\u0131n pandemiden \u00e7\u0131k\u0131p endemik bir hastal\u0131\u011fa, yani k\u0131\u015f\u0131n artan, yaz\u0131n azalan t\u0131pk\u0131 grip gibi bir hastal\u0131\u011fa d\u00f6n\u00fc\u015fme olas\u0131l\u0131\u011f\u0131 var. Ama bunu belirleyen en kritik fakt\u00f6r, yeni bir varyant\u0131n ortaya \u00e7\u0131kmamas\u0131. D\u00fcnya \u00f6n\u00fcm\u00fczdeki senenin ortalar\u0131 veya sonuna do\u011fru atlatm\u0131\u015f olabilir pandemiyi. Hatta geli\u015fmi\u015f \u00fclkeler, bizim \u00fclkemiz de dahil, \u00f6n\u00fcm\u00fczdeki y\u0131l\u0131n ortalar\u0131ndan \u00f6nce atlatabiliriz pandemiyi. Ama a\u015f\u0131dan ka\u00e7an bir varyant \u00e7\u0131karsa, bize fazladan en az 1 y\u0131l daha kaybettirir. Bu yeni varyant\u0131 engellemenin de tek yolu, insanlar\u0131n hastalanmas\u0131n\u0131 \u00f6nlemekten ge\u00e7iyor. Bu da DS\u00d6 pandemi bitti diyene kadar ki\u015fisel \u00f6nlemlere, maske mesafe temizlik, havaland\u0131rma \u00f6nlemlerine dikkat etmek, kalabal\u0131klar\u0131n bir araya gelmesini engelleyecek toplumsal k\u0131s\u0131tlamalar\u0131n bir s\u00fcre daha s\u00fcrd\u00fcr\u00fclmesi ve en \u00f6nemlisi de yayg\u0131n bir \u015fekilde a\u015f\u0131laman\u0131n ger\u00e7ekle\u015ftirilmesi ile olabilir.”<\/p>\n

Kaynak: DHA<\/p>\n","protected":false},"excerpt":{"rendered":"

Prof. Dr. Alpay Azap, “A\u015f\u0131lanma ve birka\u00e7 ay i\u00e7inde kullan\u0131ma girecek yeni ila\u00e7lar sayesinde koronavir\u00fcs pandemisinin \u00f6n\u00fcm\u00fczdeki 6-9 ay i\u00e7inde endemik…<\/p>\n","protected":false},"author":2,"featured_media":12963,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,185],"tags":[],"class_list":["post-12962","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gundem","category-manset"],"_links":{"self":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/12962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/comments?post=12962"}],"version-history":[{"count":0,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/posts\/12962\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media\/12963"}],"wp:attachment":[{"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/media?parent=12962"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/categories?post=12962"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/istanbulchannel.net\/index.php\/wp-json\/wp\/v2\/tags?post=12962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}